We have already witnessed a successful first and second congress in Fukuoka and Beijing. Following in the footsteps of these previous achievements, a wide variety of sessions covering both traditional and new topics in the field of dermatology will be included to provide an ideal platform for scientific exchange. I believe that this will be an excellent opportunity for all participants to develop their fields of interest as well as make friendships with dermatologists from different societies.

Lastly, we are confident that all of you will greatly enjoy and appreciate our choice of Jeju Island as the venue location. In contrast to bustling urban Seoul where most meetings in Korea are held, Jeju is a pinnacle of natural beauty that was recently named one of the New 7 Wonders of Nature. It is home to many amazing spectacles and formations including three UNESCO World Natural Heritage sites.

I am confident that the 3rd EADC will provide extremely rewarding and memorable experiences for all participants.

Hee Chul Eun

President of Host Society, Korean Dermatological Association

3rd Eastern Asia Dermatology Congress

So gathering three societies will bring many insights in dermatological science. The 3rd EADC will be held in Jeju Island, Korea from September 24 to 26, 2014. We believe that the 3rd EADC2014 will be a wonderful chance for you to obtain updated knowledge in dermatology and keep in touch with friends in other societies. Please join us and enjoy the 3rd EADC in Jeju Island. I hope to share these precious experience and knowledge with all dermatologists in Eastern Asia.

Chikako Nishigori

The Japanese Dermatological Association-Appointed President

3rd Eastern Asia Dermatology Congress

On behalf of the Chinese Society of Dermatology and Chinese colleagues, I hereby express our gratitude to Korean Society of Dermatology and Korean dermatologists. Thank you very much for your great effort and contribution to this congress. All the best to the colleagues from Korea, Japan, China and other eastern Asian districts and countries. I wish everyone a good health and prosperity in life.

Jie Zheng

President-Elect of Chinese Society of Dermatology

3rd Eastern Asia Dermatology Congress

Rules for abstract submission

• Authors are required to indicate their preference for either oral or poster presentation by checking the appropriate box on the submission web page. The Scientific Committee, however, reserves the right to make the final decision on the mode of presentation.
• Acceptance or rejection of abstracts will be based on rankings given by a peer review of experts in the associated topic. Results of the selection process will be sent out via e-mail. The reviewers’ decision is final and cannot be appealed.
• Abstracts should contain original work that has not been published at national or international meetings prior to the EADC 2014.
• You must choose and submit a Basic Research or Clinical Study or Case Report abstract. Either abstract type is acceptable.
• Instructions on the preparation of posters and information regarding projection facilities will be included with the notification of acceptance.
• Submission of an abstract indicates acceptance of and compliance with the abstract submission rules, the scientific validity of the presentation and that all authors have read and approved the abstract and its contents.
• All accepted abstracts will be published on a EADC2014 Abstract CD and distributed to all delegates.
• Accepted abstracts are official communications of the Congress. The presenting author agrees to register, attend the Congress and present the abstracts as scheduled. The presenting author must register at the time that his or her abstract is accepted. Accepted abstracts with no registered authors by July, 31, 2014 will not be published.

Instructions for abstract preparation

• Abstracts must be written and presented in English.
• Title : Use a concise title that indicates the content of the abstract. The complete title should be capitalized and should not exceed 25 words. Refrain from using abbreviations in the title.
• Authors : Names and surnames for each author must be provided. Do not include degrees or titles. Presenting authors’ names will be underlined and corresponding authors’ name will be in bold.
  - Names should be written in first (given) name last (family) name order. 
  - Affiliations: Each author should be listed by department, institution and country.
• Keyword: A minimum of three (3) keywords, summarizing the contents of the abstract, should be entered.
• Text: Abstracts should not exceed 300 words. Abstracts will be reproduced exactly as submitted and will not be edited in any way.
• Contents may be organized as the author sees fit, though they should include the purpose of the study, the methods used, a summary of the results and the conclusion reached. It is not satisfactory to simply state that “The result will be discussed:”
• Following the instructions above, case reports abstracts may be written in any format according to the author’s preference. Basic Research and Clinical Study, however, should be written using category blocks in the given format (see sample abstract).
• Only standard abbreviations may be used without definition.
• Drug products should be identified by their generic name only.
• Data must be given in units (International metric systb is preferred) widely used in literature.
• Neither commercial drug names nor pharmaceutical company names may be used in the abstract. EADC2014 will not be responsible for abstract contents.
• No references, tables, charts or drawings are allowed.
• Only a limited number of abstracts selected by the Scientific Program Committee will be presented as oral communications. Others will be accepted as posters.

Abstract Topics

For reviewing and scheduling purposes, abstracts will be categorized into the themes listed below. Please indicate on the submission page the appropriate topic classifications to which your abstract belongs.

Others

• Statement of Responsibility 
  - The co-authors agree with the stated results and have consented to inclusion as authors.
  - This abstract has not been submitted to any other international meeting.
  - Work involving humans or animals, or material derived from them. was approved by an institutional ethics    committees.
• Modifications may be made before the abstract submission system is closed.
• Authors who wish to withdraw their abstract should send a written request to: abstract@eadc2014.org
• Online Submission will be available on the Congress website from January 2014. Please follow the instructions detailed on the website. Your abstract submission will be acknowledged automatically by mail.E-MAIL OR FAX SUBMISSIONS WILL NOT BE ACCEPTED.
• Presentation guidelines will also be sent after your abstract submission is complete.

Acceptance Notification

Information will be sent by June 30, 2014 regarding session allocation, requirements and instructions for oral and poster presentations. If your abstract is accepted, please be sure to register no later than July, 31, 2014. If you do not register in time, your abstract may not be included on the EADC2014 Abstract CD.